The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma

MLA

Xu Han, et al. “The Combined Signatures of Telomere and Immune Cell Landscape Provide a Prognostic and Therapeutic Biomarker in Glioma.” Frontiers in Immunology, vol. 14, Aug. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1220100.

APA

Xu Han, Zihan Yan, Kaiyu Fan, Xueyi Guan, Bohan Hu, Xiang Li, Yunwei Ou, Bing Cui, Lingxuan An, Yaohua Zhang, & Jian Gong. (2023). The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1220100

Chicago

Xu Han, Zihan Yan, Kaiyu Fan, Xueyi Guan, Bohan Hu, Xiang Li, Yunwei Ou, et al. 2023. “The Combined Signatures of Telomere and Immune Cell Landscape Provide a Prognostic and Therapeutic Biomarker in Glioma.” Frontiers in Immunology 14 (August). doi:10.3389/fimmu.2023.1220100.